CIHR COVID-19 Investments: By the Numbers

Since the start of the pandemic, CIHR has invested $236.4M in COVID-19 research, to which partner organizations have added $20.2M, for a total investment of $256.6M. These funds have been used to support 556 research grants. The majority of this funding has come from one-time investments in CIHR from the Government of Canada specifically for COVID-19 research.

These figures are current as of June 10, 2021, and will be updated as new investments are announced.

556 grants funded, $256.6M total investment, 0 bridge grants

Investment breakdown

Long Description
Competition Amount Invested
First COVID-19 Rapid Research funding competition (February 2020) $55.3M
Canadian Immunization Research Network (CIRN) $997,600
Canadian Treatments for COVID-19 (CATCO) trial $3.55M
Canadian Treatments for COVID-19 (CATCO) trial – supplementary funding $3.5M
Frailty and COVID-19 in older adults $297,200
Supplementary funding: Sex as a biological variable $664,700
Canadian Venous Thromboembolism Research Network (CanVECTOR) and Canadian Critical Care Trials Group $300,000
Canadian Research Initiative in Substance Misuse (CRISM) urgent guideline activities related to COVID-19 $1M
Second COVID-19 Rapid Research funding competition (April 2020) $123.5M
Mental health knowledge synthesis grants $2.1M
Mental health operating grants $10.3M
Legal frameworks for vaccination $240,700
Canadian Immunization Research Network – vaccine readiness $3.5M
Strengthening pandemic preparedness in long-term care homes $3.1M
Canadian International COVID-19 Surveillance Border Study $2.5M
Canadian Longitudinal Study on Aging (CLSA) $1.2M
COVID-19 research gaps and priorities $18.7M
Canadian Network of COVID-19 Clinical Trials Networks $6M
Evaluation of harm-reduction approaches to address the opioid crisis during COVID-19 $2.1M
Knowledge synthesis network $1M
Indigenous COVID-19 research $2M
Network for Emerging Variants $9M
Supplementary funding – COVID-19 variants $5.4M

Read more about these funding opportunities and the individual projects funded.

Learn how this research was funded and read about how Canadian research offers hope in the fight against COVID-19.

Read more about equity, diversity and inclusion in CIHR’s COVID-19 competitions.
Note: We are currently pulling together the data to break down the results of our COVID competitions further, and will make them available soon.

Timeline of investments

Long Description
Competition Launch Date
First COVID-19 Rapid Research funding competition February 2020
Canadian Immunization Research Network (CIRN) March 2020
Supplementary funding: Sex as a biological variable April 2020
Second COVID-19 Rapid Research funding competition (April 2020) April 2020
Mental health knowledge synthesis grants April 2020
Canadian Research Initiative in Substance Misuse (CRISM) urgent guideline activities related to COVID-19 April 2020
Frailty and COVID-19 in older adults April 2020
Canadian Treatments for COVID-19 (CATCO) trial April 2020
Canadian Venous Thromboembolism Research Network (CanVECTOR) and Canadian Critical Care Trials Group May 2020
Mental health operating grants June 2020
Legal frameworks for vaccination July 2020
Canadian Immunization Research Network – vaccine readiness August 2020
Strengthening pandemic preparedness in long-term care homes September 2020
Indigenous COVID-19 research September 2020
Canadian International COVID-19 Surveillance Border Study October 2020
Knowledge synthesis network October 2020
Evaluation of harm-reduction approaches to address the opioid crisis during COVID-19 October 2020
Canadian Longitudinal Study on Aging (CLSA) November 2020
Canadian Network of COVID-19 Clinical Trials Networks November 2020
Emerging COVID-19 research gaps and priorities – I November 2020
Supplementary funding – COVID-19 variants February 2021
Network for Emerging Variants February 2021
COVID-19 research gaps and priorities - II March 2021
Canadian Treatments for COVID (CATCO) trial – supplementary funding March 2021

Investments across Canada

Long Description
Province/Territory Number of projects
Alberta 81
British Columbia 80
Manitoba 18
Newfoundland and Labrador 3
New Brunswick 2
Northwest Territories 0
Nova Scotia 21
Nunavut 1
Ontario 236
Prince Edward Island 1
Quebec 94
Saskatchewan 19
Yukon 0

Partner Investments

Long Description
Partner Funding amount
International Development Research Centre (IDRC) $8M
Social Sciences and Humanities Research Council (SSHRC) $7.86M
Alberta Innovates $946,100
Research Manitoba $900,000
Ontario Ministry of Health and Long-term Care $750,000
Natural Sciences and Engineering Research Council of Canada (NSERC) $714,000
Michael Smith Foundation for Health Research $250,000
Genome Canada $244,000
Research Nova Scotia $225,000
Saskatchewan Health Research Foundation $150,000
New Brunswick Health Research Foundation $100,000
Centre for Aging and Brain Health $75,000

COVID-19 international linkages

Long Description
Country affiliation N projects (Total)
Argentina 1
Australia 23
Austria 2
Bangladesh 1
Belgium 1
Benin 1
Brazil 10
Burkina Faso 1
Chile 3
China 14
Colombia 4
Czech Republic 1
Democratic Republic of Congo 1
Ecuador 3
Egypt 1
England 6
Ethiopia 1
Finland 1
France 10
Germany 4
Ghana 1
Greece 1
Guinea 1
Hong Kong 5
India 8
Indonesia 1
Iran 1
Ireland 1
Italy 7
Kenya 3
Lebanon 1
Lesotho 1
Malawi 1
Malaysia 1
Mali 2
Mauritius 1
Mexico 5
Netherlands 5
New Zealand 3
Nigeria 1
Norway 3
Pakistan 4
Peru 1
Philippines 5
Poland 1
Russia 2
Rwanda 1
Saudi Arabia 2
Senegal 1
Sierra Leone 2
Singapore 3
South Africa 6
South Korea 1
Spain 3
Sri Lanka 1
Sweden 8
Switzerland 5
Tanzania 2
Thailand 3
Turkey 1
Uganda 1
United Arab Emirates 2
United Kingdom 33
United States 115
Vietnam 2
Zimbabwe 1
Date modified: